Mad in America

JANUARY 3, 2024

The results , which Rush reported in 2004 , were dispiriting. Only 26% of the real-world patients responded to the antidepressant during the first year of treatment (meaning that their symptoms decreased by at least 50% on a rating scale), and only about half of that group had a “sustained response.” Show 2 footnotes D.

Neurotransmitters and mental health 145

Neurotransmitters and mental health Hospitality Education Self-awareness 145

Mad in America

JANUARY 4, 2025

American psychiatry has weathered the crisis; it will not have to confront a public stunned by news of how the oft-cited 67% cumulative remission rate, in the largest and longest study ever done to evaluate depression treatment,” was born of scientific misconduct.

Neurotransmitters and mental health 145

Neurotransmitters and mental health Pharmaceuticals Sleep and mental health Aging and mental health 145

Mad in America

MARCH 15, 2025

Psychiatric News reported in 2024 that PubMed shows more than 400 trials of ketamine as a depression treatment in the past decade; however, it also reports that G. The same disregard for the scientific method that establishment psychiatry evidenced in standard antidepressant drug trials is now evident with ketamine.

Neurotransmitters and mental health 136

Neurotransmitters and mental health Trauma and the brain Manufacturing Pharmaceuticals 136